Physostigmine in eyedrops decreases craving for alcohol in early withdrawal treated with carbamazepine.
D000328:Adult; D000437:Alcoholism / Q000188:drug therapy*; D002220:Carbamazepine / Q000008:administration & dosage* / Q000627:therapeutic use; D004357:Drug Synergism; D000431:Ethanol / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010830:Physostigmine / Q000008:administration & dosage*; D011897:Random Allocation; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000523:psychology
D009883:Ophthalmic Solutions; D002220:Carbamazepine; D000431:Ethanol; D010830:Physostigmine